Askerlerde Cinsel Yolla Bulaşan Enfeksiyonlar ve Korunma

Cinsel yolla bulaşan enfeksiyon (CYBE)'lar bütün dünyada yaygın olarak görülen ve sıklığı giderek artan önlenebilir ciddi mortalite ve morbiditeye sahip hastalıklardır. cinsel aktivitenin en yoğun olduğu 15-35 yaş grubunda saptanırlar. Askeri popülasyon, cinsel aktivasyonun en ileri safhada olduğu genç erişkin gruptur. Birçok ülkede bu yaş dönemindeki erkekler 1-2 yıl süreyle askere alınmakta, evli olanlar uzun süre eşlerinden ayrı kalmakta, evli olmayanlar da evliliklerini ertelemek zorunda kalmaktalar dır. Bu durumun doğal bir sonucu olarak, CYBE açısından risk artışı olabilmektedir.

Sexually Transmitted Infections and Protection in Soldiers

Sexually transmitted infections (STI) are common and the prevalence is increasing all over the world. These diseases have a significant mortality and morbidity can be prevented. These diseases are seen in the age group of 15-35 is more intense sexual activity. Military population, the most advanced stage of sexual activation in the young adult group. In many countries, men in this age period have been recruited for a period of 1-2 years; the wives of married people separate staying for a long time, those that are not married are obliged to postpone their marriage. As a natural consequence of this circumstances, may increase the risk of STI.

PDF

___

1. HIV tedavi bülteni Türkiye. http://ibase.info/files/2011/05/hiv_tedavi_bulteni_turkiy e_nisan_20121.pdf [Erişim Tarihi 31.05.2012].
2.___AIDS/info_Turkey._http://www.unaids.org/en/reg ionscountries/countries/turkey/. [Erişim Tarihi 31.05.2012].
3. Adler M. Epidemiology and Public Health Issues in Sexually Transmitted Infections. In: Cohen J, Powderly WG, editors. Infectious Diseases. 2 ed. Edinburg Mosby; 2004, p. 785-793.
4. Sexually Transmitted Diseases (STDs). http://www.cdc.gov/std/. [Erişim Tarihi 31.05.2012].
5. Malone JD, Hyams KC, Hawkins RE, Sharp TW, Daniell FD. Risk factors for sexually-transmitted diseases among deployed U.S. military personnel. Sexually transmitted diseases. 1993; 20(5): 294-298.
6. Masterton RG, Strike PW. Sexually transmitted diseases in a British military force in peacetime Europe, 1970-83. Genitourinary medicine. 1988; 64(1): 54-58.
7. Şaşmaz S, Çalka Ö, Altınyazar HC. Kuzey Kıbrıs Türk Cumhuriyeti'nde Görev Yapan Askerlerde Cinsel Yolla Bulaşabilen Hastalıkların Sıklığı. ÇÜ Tıp Fak Dergisi. 2003; 28: 88-93.
8. Guptill KS, Hargarten SW, Baker TD. American travel deaths in Mexico. Causes and prevention strategies. The Western journal of medicine. 1991; 154(2): 169-171.
9. Hargarten SW, Baker TD, Guptill K. Overseas fatalities of United States citizen travelers: an analysis of deaths related to international travel. Annals of emergency medicine. 1991; 20(6): 622-626.
10. Beşirbellioğlu AB. Yurtdışına giden personel için proflaksi esasları. TAF Preventive Medicine Bulletin. 2006; 5(3): 204-211.
11. Ünal S, Zarakolu IP. Cinsel yolla bulaşan enfeksiyonlar ve genel özellikler. Eds.: Topçu AW, Söyletir G. Enfeksiyon Hastalıkları ve Mikrobiyolojisi. İstanbul: Nobel Tıp Basımevi, 2008, p. 1549-1562.
12. 2010 STD Treatment Guidelines. http://www.cdc.gov/std/treatment/2010/. [Erişim Tarihi: 31.05.2012].
13. Mast EE, Weinbaum CM, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep. [Practice Guideline]. 2006; 55(RR-16): 1-33; quiz CE1-4.
14. Trepka MJ, Weisbord JS, Zhang G, Brewer T. Hepatitis B virus infection risk factors and immunity among sexually transmitted disease clinic clients. Sexually transmitted diseases. [Research Support, Non-U.S. Gov't]. 2003; 30(12): 914-918.
15. Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet. [Research Support, Non-U.S. Gov't]. 2006; 367(9518): 1247-1255.
16. Auvert B, Sobngwi-Tambekou J, Cutler E, et al. Effect of male circumcision on the prevalence of high-risk human papillomavirus in young men: results of a randomized controlled trial conducted in Orange Farm, South Africa. J Infect Dis. [Comment Randomized Controlled Trial Research Support, Non-U.S. Gov't]. 2009; 199(1): 14-19.
17. Hook EW, 3rd. An ounce of prevention. Ann Intern Med. [Comment Editorial Research Support, N.I.H., Extramural]. 2005; 143(10): 751- 752.
18. Davis KR, Weller SC. The effectiveness of condoms in reducing heterosexual transmission of HIV. Fam Plann Perspect. [Review]. 1999; 31(6): 272-279.
19. Isbey SF, Alcorn TM, Davis RH, Haizlip J, Leone PA, Cohen MS. Characterisation of Neisseria gonorrhoeae in semen during urethral infection in men. Genitourin Med. [Research Support, U.S. Gov't, P.H.S.]. 1997; 73(5): 378-382.
20. Holmes KK, Levine R, Weaver M. Effectiveness of condoms in preventing sexually transmitted infections. Bull World Health Organ. [Research Support, U.S. Gov't, Non-P.H.S. Review]. 2004; 82(6): 454-461.
21. Al-Tawfiq JA, Harezlak J, Katz BP, Spinola SM. Cumulative experience with Haemophilus ducreyi 35000 in the human model of experimental infection. Sexually transmitted diseases. 2000; 27(2): 111-114.
22. Koss CA, Dunne EF, Warner L. A systematic review of epidemiologic studies assessing condom use and risk of syphilis. Sexually transmitted diseases. 2009; 36(7): 401-405.
23. Ness RB, Randall H, Richter HE, et al. Condom use and the risk of recurrent pelvic inflammatory disease, chronic pelvic pain, or infertility following an episode of pelvic inflammatory disease. Am J Public Health. [Research Support, U.S. Gov't, P.H.S.]. 2004; 94(8): 1327-1329.
24. Wilkinson D, Tholandi M, Ramjee G, Rutherford GW. Nonoxynol-9 spermicide for prevention of vaginally acquired HIV and other sexually transmitted infections: systematic review and meta-analysis of randomised controlled trials including more than 5000 women. Lancet Infect Dis. [Meta-Analysis Research Support, Non-U.S. Gov't Review]. 2002; 2(10): 613-617.
25. Sobngwi-Tambekou J, Taljaard D, Lissouba P, Zarca K, Puren A, Lagarde E, et al. Effect of HSV-2 serostatus on acquisition of HIV by young men: results of a longitudinal study in Orange Farm, South Africa. J Infect Dis. [Randomized Controlled Trial Research Support, Non-U.S. Gov't]. 2009; 199(7): 958-964.
26. Reduction HIV acquisition circumcised. www.niaid.nih.gov/news/newsreleases/2008/Pag es/circumcision_update.aspx. [Erişim Tarihi: 31.05.2012].
27. Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. [Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't]. 2007; 369(9562): 643-656.
28. Schillinger JA, McKinney CM, Garg R, et al. Seroprevalence of herpes simplex virus type 2 and characteristics associated with undiagnosed infection: New York City, 2004. Sexually transmitted diseases. [Research Support, NonU.S. Gov't]. 2008; 35(6): 599-606.
29. Gray RH, Kigozi G, Serwadda D, et al. The effects of male circumcision on female partners' genital tract symptoms and vaginal infections in a randomized trial in Rakai, Uganda. Am J Obstet Gynecol. [Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't]. 2009; 200(1): 42 e1-7.
30. Tobian AA, Serwadda D, Quinn TC, et al. Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N Engl J Med. [Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't]. 2009; 360(13): 1298-1309.
31. Cutler B, Justman J. Vaginal microbicides and the prevention of HIV transmission. Lancet Infect Dis. [Research Support, N.I.H., Extramural Review]. 2008; 8(11): 685-697.
32. Padian NS, van der Straten A, Ramjee G, et al. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet. [Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't]. 2007; 370(9583): 251- 261.
33. Hook EW, 3rd, Stephens J, Ennis DM. Azithromycin compared with penicillin G benzathine for treatment of incubating syphilis. Ann Intern Med. [Clinical Trial Comparative Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]. 1999; 131(6): 434-437.
34. Thornton AC, O'Mara EM, Sorensen SJ, et al. Prevention of experimental Haemophilus ducreyi infection: a randomized, controlled clinical trial. J Infect Dis. [Clinical Trial Randomized Controlled Trial Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]. 1998; 177(6): 1608-1613.
35. Freedman DO. Protection of Travelers. Eds.: Mandell GL, Bennett JE, Dolin R. Principles and Practice of Infectious Diseases: Elsevier Churchill Livingstone, 2005, p. 3637-3646.